OCUL
Companies
NASDAQ
Ocular Therapeutix Inc.
Health Care
$8.33
-$0.41 (-4.80%)
Price Chart
Overview
About OCUL
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Market Cap
$765.2M
Volume
16.3M
Avg. Volume
15.1M
P/E Ratio
-5.901961
Dividend Yield
0.00%
Employees
270.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.39
High Correlation
Volatility
High (0.70)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, OCUL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$765.2M
Volume16.3M
P/E Ratio-5.90
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 3, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025